Fundraising FoxPhAST
Boston, US · Founded 2017 · Delaware corporation
Find your way into PhAST
Sign up to see every warm intro you have to PhAST
- Paths you didn't know you had: your email and LinkedIn already hold routes to the PhAST team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
PhAST develops AI and machine learning imaging technology for infectious disease diagnostics, using single-cell imaging and a cloud-based platform to address antibiotic resistance. Its platform provides clinical decision support for doctors, workflow tools for hospitals, and drug development support for pharmaceutical companies.
Founders & leadership
PhAST was founded in 2017 by Roman Stocker and Kwangmin Son.
Reported raises · per SEC filings
Form D private placements$18.6M disclosed across 3 rounds · 2021–2025
▶$3.5MraisedApr 2025 · 5 investors · BiotechnologyRule 506(b)
- Roman StockerExecutive Officer, Director
- Kwangmin SonExecutive Officer, Director
- Offering amount
- $8M
- Amount sold
- $3.5M
- First sale
- Apr 2025
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$4.4MraisedDec 2022 · 3 investors · BiotechnologyRule 506(b)
- Roman StockerExecutive Officer, Director
- Kwangmin SonExecutive Officer, Director
- Offering amount
- $14M
- Amount sold
- $4.4M
- First sale
- Dec 2022
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$10.8MraisedOct 2021 · 15 investors · Other TechnologyRule 506(b)
- Kwangmin SonExecutive Officer, Director
- Roman StockerExecutive Officer, Director
- Offering amount
- $19M
- Amount sold
- $10.8M
- First sale
- Oct 2021
- Incorporated
- Corporation, Delaware, 2017
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Related companies · 1
Companies working in the same space as PhAST.
In the news
Frequently asked questions
- What does PhAST do?
- PhAST develops AI and machine learning imaging technology for infectious disease diagnostics, using single-cell imaging and a cloud-based platform to address antibiotic resistance. Its platform provides clinical decision support for doctors, workflow tools for hospitals, and drug development support for pharmaceutical companies.
- Who founded PhAST?
- PhAST was founded by Roman Stocker, Kwangmin Son in 2017.
- How much funding has PhAST raised?
- PhAST has disclosed $18.6M raised across 3 rounds.
- Where is PhAST headquartered?
- PhAST is headquartered in Boston, US.